Systematic review: Safety and efficacy of anti-TNF in elderly patients

Alamanos, 2006, Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review, Semin Arthritis Rheum., 36, 182, 10.1016/j.semarthrit.2006.08.006 Carmona, 2007, BIOBADASER and EMECAR Groups All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists, Ann Rheum Dis., 66, 880, 10.1136/ard.2006.067660 University of Oxford. Centre for Evidence-based Medicine Levels of Evidence. (May 2001). Genevay, 2007, Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: A population-based cohort study, Rheum., 57, 679, 10.1002/art.22688 Schneeweiss, 2007, Antitumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis, Arthritis Rheum., 56, 1754, 10.1002/art.22600 Massara, 2007, Section of Rheumatology, Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara Italy. High incidence of serious adverse events among elderly rheumatoid patients receiving monoclonal antibodies anti-TNF alpha, Abstract EULAR Schiff, 2006, Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies, Drugs Aging., 23, 167, 10.2165/00002512-200623020-00006 Fleischmann, 2006, Long term safety of etanercept in elderly subjects with rheumatic diseases, Ann Rheum Dis., 65, 379, 10.1136/ard.2005.035287 Bathon, 2006, Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis, Journal of Rheumatology., 33, 234 Mariette, 2006, Treatment with Adalimumab (Humira®) is Well-Tolerated and Efficacious in Patients with Active RA in Various Age Groups Including Patients with Late-Onset RA: Subanalysis of 6610 Patients in the ReAct Trial, Abstract ACR Dabbous, 2006, Impact of Age on Outcomes of Japanese Patients with Rheumatoid Arthritis Treated with Infliximab: The Post Marketing Surveillance Trial, Abstract ACR Chevillotte-Maillard, 2005, Survival and safety of treatment with infliximab in the elderly population, Rheumatology., 44, 695, 10.1093/rheumatology/keh562 Fleischmann, 2003, Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results, J Rheumatol., 30, 691 Fleischmann, 2007, Risk: Benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis, Drugs Aging., 24, 239, 10.2165/00002512-200724030-00005 Diaz-Borjon, 2006, Treatment of chronic inflammatory diseases with biologic agents: Opportunities and risks for the elderly, Experimental Gerontology., 41, 1250, 10.1016/j.exger.2006.10.010 Fleischmann, 2006, Safety and efficacy of etanercept in the elderly, J Aging Health., 2, 189, 10.2217/1745509X.2.2.189 Ornetti, 2006, Anti-tumour necrosis factor-alpha therapy for rheumatoid and other inflammatory arthropathies: Update on safety in older patients, Drugs and Aging., 23, 855, 10.2165/00002512-200623110-00001 Harrison, 2005, Does age bias the aggressive treatment of elderly patients with rheumatoid arthritis?, J Rheumatol., 32, 1243 Legrand, 2005, Anti-TNF alpha chez le sujet âgé: profil des patients et tolerance, Rev Rhum., 72, 974 Zih, 2003, The biologic treatments for inflammatory arthritis: Is there a role in the elderly?, Drugs and Aging., 6, 61 Salliot, 2007, Infections during tumour necrosis factor alpha blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patients, Rheumatology., 46, 327, 10.1093/rheumatology/kel236 Maillard, 2005, Severe pyogenic infections in patients taking infliximab: a regional cohort study, Joint Bone Spine., 72, 330, 10.1016/j.jbspin.2004.09.003